CURE.DE vs. CBUF.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and CBUF.DE (iShares MSCI World Health Care Sector ESG UCITS ETF USD Dist) are both Health & Biotech Equities funds - CURE.DE tracks the MVIS Global Future Healthcare ESG while CBUF.DE tracks the MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 0.62%/yr for CBUF.DE. A 0.55 correlation means they provide meaningful diversification when combined. CURE.DE charges 0.35%/yr vs 0.18%/yr for CBUF.DE.
Performance
CURE.DE vs. CBUF.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than CBUF.DE's -2.22% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 7.19%
- YTD
- -5.10%
- 6M
- -8.94%
- 1Y
- 5.80%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
CBUF.DE
- 1D
- 2.74%
- 1M
- 3.91%
- YTD
- -2.22%
- 6M
- -1.50%
- 1Y
- 7.40%
- 3Y*
- 0.62%
- 5Y*
- 4.66%
- 10Y*
- —
CURE.DE vs. CBUF.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -4.35% |
CBUF.DE iShares MSCI World Health Care Sector ESG UCITS ETF USD Dist | -2.22% | 2.56% | 0.75% | 0.33% | 3.31% |
Correlation
The correlation between CURE.DE and CBUF.DE is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.53 |
Correlation (All Time) Calculated using the full available price history since Sep 8, 2022 | 0.55 |
The correlation between CURE.DE and CBUF.DE has been stable across timeframes, ranging from 0.53 to 0.60 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. CBUF.DE — Risk / Return Rank
CURE.DE
CBUF.DE
CURE.DE vs. CBUF.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and iShares MSCI World Health Care Sector ESG UCITS ETF USD Dist (CBUF.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | CBUF.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.24 | ||
| Sortino ratioReturn per unit of downside risk | -0.32 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.10 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 0.68 | -0.37 |
| Martin ratioReturn relative to average drawdown | 0.68 | 1.56 | -0.88 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | CBUF.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 0.53 | -0.24 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.34 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.44 | -0.58 |
Drawdowns
CURE.DE vs. CBUF.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, which is greater than CBUF.DE's maximum drawdown of -25.94%. Use the drawdown chart below to compare losses from any high point for CURE.DE and CBUF.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | CBUF.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -25.94% | -8.86% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -10.87% | -8.20% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -21.76% | -7.56% |
Max Drawdown (5Y)Largest decline over 5 years | — | -21.76% | — |
Current DrawdownCurrent decline from peak | -15.66% | -9.66% | -6.00% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -5.65% | -9.47% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 4.74% | +3.79% |
Volatility
CURE.DE vs. CBUF.DE - Volatility Comparison
VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a higher volatility of 5.73% compared to iShares MSCI World Health Care Sector ESG UCITS ETF USD Dist (CBUF.DE) at 4.98%. This indicates that CURE.DE's price experiences larger fluctuations and is considered to be riskier than CBUF.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | CBUF.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 4.98% | +0.75% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 9.70% | +5.50% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 13.98% | +5.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 13.60% | +7.14% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 15.36% | +5.38% |
CURE.DE vs. CBUF.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is higher than CBUF.DE's 0.18% expense ratio.
Dividends
CURE.DE vs. CBUF.DE - Dividend Comparison
CURE.DE has not paid dividends to shareholders, while CBUF.DE's dividend yield for the trailing twelve months is around 1.08%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
CBUF.DE iShares MSCI World Health Care Sector ESG UCITS ETF USD Dist | 1.08% | 1.06% | 1.02% | 1.16% | 1.09% | 1.05% | 1.27% | 0.10% |
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CURE.DE and CBUF.DE have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CBUF.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CBUF.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for CURE.DE.
CURE.DE tracks MVIS Global Future Healthcare ESG, while CBUF.DE tracks MSCI World Health Care ESG Reduced Carbon Select 20 35 Capped. They also come from different issuers: VanEck and iShares. Their fees differ too: 0.35% for CURE.DE and 0.18% for CBUF.DE.
Find the right allocation for CURE.DE and CBUF.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer